Barclays lowered the firm’s price target on GSK (GSK) to 1,450 GBp from 1,550 GBp and keeps an Equal Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GSK Pharma put volume heavy and directionally bearish
- GlaxoSmithKline (GSK) Announces Q1 Dividend: Save the Dates!
- GlaxoSmithKline Updates Share Capital and Voting Rights
- GSK price target lowered to 1,440 GBp from 1,550 GBp at JPMorgan
- GSK price target lowered to 1,700 GBp from 1,850 GBp at Deutsche Bank